# Dose-ranging Study of SPL7013 Gel for the Prevention of Bacterial Vaginosis (BV)

> **NCT01437722** · PHASE2 · COMPLETED · sponsor: **Starpharma Pty Ltd** · enrollment: 205 (actual)

## Conditions studied

- Recurrent Bacterial Vaginosis (BV)

## Interventions

- **DRUG:** 1% SPL7013 Gel
- **DRUG:** 3% SPL7013 Gel
- **DRUG:** placebo gel

## Key facts

- **NCT ID:** NCT01437722
- **Lead sponsor:** Starpharma Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2012-12
- **Final completion:** —
- **Target enrollment:** 205 (ACTUAL)
- **Last updated:** 2013-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01437722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01437722, "Dose-ranging Study of SPL7013 Gel for the Prevention of Bacterial Vaginosis (BV)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01437722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*